Osteoporosis Clinical Trials

Showing 121-140 of 353 trials

High Intensity Multi-Modal Exercise Training in Postmenopausal Women

NCT04653350

in Pakistan 9.9 million people are osteoporotic and 7.2 million amongst them are women. Globally after every 3 seconds there is occurrence of fragility fracture.In Pakistan females carries different risk factors based on distinct culture, environment, diet and lifestyle. So there is dire need to conduct more high quality clinical trials at National level in order to establish strong evidence in favor of low cost but highly effective exercise protocols for such a significant public health issue.

Postmenopausal OsteoporosisPostmenopausal Osteopenia

Riphah International University58 participantsStarted Nov 2020

Rawalpindi, Punjab Province, Pakistan • Rawalpindi, Punjab Province, Pakistan

UNKNOWNPHASE4

Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis

NCT05387200

This study aims to prove non-inferiority of the efficacy of Masibone S (alendronate sodium trihydrate 70mg, oral solution) on the treatment of postmenopausal osteoporosis compared to the efficacy of Fosamax (alendronate sodium 70mg, oral tablet). The effect of Masibone S and Fosamax on bone mineral density in postmenopausal women with osteoporosis will be compared and analyzed. This study included a total 170 patients (85 per subgroup) for multi-center, randomized, open-label, parallel clinical trial. The drugs will be maintained for a total of 48 weeks. The primary endpoint is the difference of bone mineral density change at lumbar spine measured by DEXA between two groups.

Osteoporosis

Yonsei University170 participantsStarted Jul 2021

Seoul, South Korea

High Intensity Multi-Modal Exercise Training in Postmenopausal Women

Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis

Related Searches

C-STOP Fracture Trial

Yogurt Supplementation to Alter Bone Biomarkers, the Gut Microbiota and Inflammation in Older Adults

Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients

Addressing Vertebral Osteoporosis Incidentally Detected to Prevent Future Fractures

Effects of Low-level Mechanical Vibration on Bone Density in Ambulant Children Affected by Duchenne Muscular Dystrophy

Study of Investigational Drug in Osteoporosis (MK-0217-908)

Effect of Two Exercise Programs on Bone Strength and Architecture

The Effect of Horizontal Whole-body Vibration Therapy in Post-menopausal Women

Study to Evaluate and Compare the Bioequivalence of Two Abaloparatide-sMTS Treatments in Healthy Women.

Simvastatin to Prevent SCI-Induced Bone Loss

A Retrospective Comparison Between CPS and HC Techniques for Osteoporotic Fractures in the Thoracic or Lumbar Spine

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

Alendronate Versus Denosumab in Kidney Transplant Patients

Osteoporosis and Haemophilia

A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture

Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment

Changes of Bone Turnover Markers and Bone Mineral Density After Osteoporosis Treatment

Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy